Article

Allergan Foundation donates $2 million to UC-Irvine

The University of California-Irvine's department of ophthalmology received $2 million from the philanthropic arm of Allergan Inc., The Allergan Foundation. The donation will further strengthen the department's research agenda and clinical care. The gift was "the largest donation ever to ophthalmology," according to a joint press release from the university and Allergan.

The University of California-Irvine's department of ophthalmology received $2 million from the philanthropic arm of Allergan Inc., The Allergan Foundation. The donation will further strengthen the department's research agenda and clinical care. The gift was "the largest donation ever to ophthalmology," according to a joint press release from the university and Allergan.

In the future, UC-Irvine would like to develop a new facility called The Eye Institute. The facility would be dedicated to teaching, clinical care, and research on retinal diseases including diabetic retinopathy, macular degeneration, retinal degeneration, and retinitis pigmentosa. If the proposal is approved and funded, Allergan's contribution will be used to support retinal research within the institute and the department of ophthalmology.

"This generous and far-reaching gift from Allergan will have a lasting impact on the university, school of medicine, and the department of ophthalmology," said Chancellor Michael V. Drake. "The vital partnership we share with Allergan will further strengthen our position as an innovative center of excellence in ophthalmology that will improve lives in Orange County, the region, and beyond."

Some of the nation's top researchers in retinal disease, glaucoma, corneal disease, and refractive surgery work at UC-Irvine, and Allergan's donation will help them meet complex medical and surgical eye-care needs, conduct clinical research, develop programs and technologies in conjunction with industry, and seek clinical solutions to serious and debilitating eye-threatening diseases.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.